-78%

est. 2Y upside i

HealthcareSeries B

Thatch is an all-in-one platform that makes it easy to offer your employees the most personalized healthcare experience. You decide what to spend, and your team gets great health benefits.

Rank

#4044

Sector

Healthtech

Est. Liquidity

~3Y

Data Quality

Data: High

Thatch presents a risky equity opportunity for a job seeker.

Last updated: March 10, 2026

Bull (15%)+150%

Thatch successfully re-accelerates its growth by expanding its AI-powered ICHRA platform and marketplace, capturing significant market share from traditional benefits providers and larger HR platforms. This drives revenue to over $150M by 2028, justifying a $1B+ valuation at a 7x revenue multiple, a substantial increase from its current valuation.

Base (35%)+15%

Thatch maintains its niche in the ICHRA market, growing steadily but facing continued competition from both specialized vendors and larger HR/healthcare incumbents. Revenue reaches approximately $55M by 2028, leading to a modest valuation increase to around $460M, offering limited upside for common shareholders.

Bear (50%)-70%

Dominant HR and healthcare incumbents like Workday or UnitedHealth aggressively enter the personalized benefits space, commoditizing ICHRA solutions. Thatch's 7% growth stalls, and its valuation contracts to a more realistic 2-3x revenue multiple, resulting in a down round to ~$100M-$120M, wiping out most common stock value after liquidation preferences.

Est. time to liquidity~3.0 years

Preference Stack Risk

high

Funding Intensity

21%

Investors hold $84M in liquidation preferences. In an exit at or below the current $399M valuation, common stock holders would see significantly reduced returns after these preferences are paid out.

Dilution Risk

moderate

As a Series B company, Thatch will likely require additional funding rounds, leading to further dilution for existing equity holders.

Secondary Liquidity

limited

Secondary markets like Forge Global and Hiive offer limited liquidity for accredited investors, but not guaranteed for all employees and subject to company policies.

View all 20 open roles at Thatch →

Last updated: March 10, 2026

Questions to Ask at the Interview

Strategic questions based on Thatch's data — designed to show you've done your homework.

  • 1

    “Given the reported 7% YoY growth, how does Thatch plan to significantly accelerate its revenue growth to justify its Series B valuation and achieve a successful liquidity event?”

  • 2

    “With large incumbents like Oscar Health and Centene actively pursuing ICHRA solutions, what specific strategies is Thatch implementing to maintain and expand its market position?”

  • 3

    “Considering the $84M in total funding and the current valuation, what is the company's projected timeline and strategy for a liquidity event, and how does the preference stack impact potential employee equity outcomes?”

Community

Valuation Sentiment

Our model estimates -78% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.